Publicaciones en colaboración con investigadores/as de Instituto Valenciano de Oncologia (73)

2024

  1. Efficacy and safety of cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma: A multicentre real-world retrospective study from Spain and systematic review of the published data

    Journal of the European Academy of Dermatology and Venereology

  2. Main Types of Cysts in Dermatopathology: Part 1

    Revista Espanola de Patologia, Vol. 57, Núm. 1, pp. 27-41

  3. Main Types of Cysts in Dermatopathology: Part 2

    Revista Espanola de Patologia, Vol. 57, Núm. 2, pp. 97-110

  4. Repeated pancreatic resection for pancreatic metastases from renal cell Carcinoma: A Spanish multicenter study (PANMEKID)

    Surgical Oncology, Vol. 52

  5. The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

    Clinical and Translational Oncology

  6. Volumetric analysis: Rethinking brain metastases response assessment

    Neuro-Oncology Advances, Vol. 6, Núm. 1

2023

  1. A comprehensive dataset of annotated brain metastasis MR images with clinical and radiomic data

    Scientific data, Vol. 10, Núm. 1, pp. 208

  2. Growth exponents reflect evolutionary processes and treatment response in brain metastases

    npj Systems Biology and Applications, Vol. 9, Núm. 1

  3. Impact of the COVID-19 pandemic on the diagnosis and treatment of onco-hematologic patients: a discussion paper

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 1, pp. 1-25

  4. Melanoma arising in plaque-type blue nevus and dermal melanocytosis: Diagnostic and prognostic value of BAP1

    Actas Dermo-Sifiliograficas, Vol. 114, Núm. 7, pp. 636-641

  5. NLRP3 inflammasome activation and symptom burden in KRAS-mutated CMML patients is reverted by IL-1 blocking therapy

    Cell Reports Medicine, Vol. 4, Núm. 12

  6. Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort study

    Journal of the American Academy of Dermatology, Vol. 89, Núm. 1, pp. 119-127

  7. Real-World Experience with Vismodegib on Advanced and Multiple BCCs: Data from the RELIVIS Study

    Dermatology (Basel, Switzerland), Vol. 239, Núm. 5, pp. 685-693

  8. Results in mediastinal lymph node staging of surgical lung cancer: Data from the prospective cohort of the Spanish Video-Assisted Thoracic Surgery Group

    Cirugia Espanola, Vol. 101, Núm. 6, pp. 408-416

  9. Selection of Quality Indicators for the Certification of Dermato-Oncology Units: The CUDERMA Project Delphi Consensus Study

    Actas Dermo-Sifiliograficas, Vol. 114, Núm. 7, pp. 587-605

  10. The Management of Metastatic Spinal Cord Compression in Routine Clinical Practice

    Cancers, Vol. 15, Núm. 10

  11. [Translated article] Tumor Doubling Time in Skin Cancer: Can It Be Estimated and Is It Useful?

    Actas Dermo-Sifiliograficas, Vol. 114, Núm. 3, pp. T247-T252

2022

  1. Clinical and pathological features of Merkel cell carcinoma: A 4-year follow-up observational retrospective study in Spain

    Cancer Epidemiology, Vol. 76

  2. Pancreatic metastases from renal cell carcinoma. Postoperative outcome after surgical treatment in a Spanish multicenter study (PANMEKID)

    European Journal of Surgical Oncology, Vol. 48, Núm. 1, pp. 133-141

  3. Safety and efficacy of ribociclib plus letrozole in patients with HR+, HER2– advanced breast cancer: Results from the Spanish sub-population of the phase 3b CompLEEment-1 trial

    Breast, Vol. 66, pp. 77-84